Medical Weight Loss Willards, MD

Individual results vary, but clinical studies show that patients using semaglutide and tirzepatide typically lose 15-22% of their starting weight over the course of treatment. Most patients begin seeing results within the first 4-8 weeks, with continued progress throughout their program. Dr. Nawrocki will work with you to set realistic, achievable goals based on your individual health profile and circumstances.

Yes, the FDA-approved medications we use are designed for long-term weight management when used under proper medical supervision. Dr. Nawrocki monitors all patients closely through regular telehealth consultations to ensure safety and effectiveness. These medications have undergone extensive clinical testing and have proven safety profiles when administered by qualified medical professionals.

Both are FDA-approved GLP-1 receptor agonists that help with weight loss, but tirzepatide also targets GIP receptors, potentially providing additional metabolic benefits. Tirzepatide studies show slightly higher average weight loss (up to 22.5%) compared to semaglutide (around 15%). Dr. Nawrocki will evaluate your specific health profile to determine which medication is most appropriate for your needs.

Most patients have telehealth follow-up appointments every 4 weeks during the active weight loss phase. These virtual consultations allow Dr. Nawrocki to monitor your progress, address any concerns, and adjust your treatment as needed. Once you reach your goal weight, appointments may become less frequent as you transition to maintenance care.

Yes, our comprehensive medical weight loss program is available entirely through telehealth for Willards residents. Virtual consultations are highly effective for medication management, progress monitoring, and ongoing support. This convenient approach allows you to receive expert medical care without the need for frequent office visits while maintaining the highest standards of safety and effectiveness.

Medical weight loss addresses the biological and hormonal factors that contribute to weight gain, rather than relying solely on willpower and calorie restriction. Our FDA-approved medications help regulate appetite hormones, reduce cravings, and improve metabolism, making it easier to achieve and maintain weight loss without the frustration often associated with traditional dieting methods.

Ideal candidates typically have a BMI of 27 or higher with weight-related health conditions, or a BMI of 30 or higher. Our program is particularly beneficial for individuals who have struggled with traditional weight loss methods or have underlying metabolic issues contributing to weight gain. Dr. Nawrocki will evaluate your medical history during your initial consultation to determine if you’re a suitable candidate.

Most patients begin experiencing reduced appetite and initial weight loss within the first 2-4 weeks of treatment. Significant weight loss typically becomes apparent by 8-12 weeks, with continued progress throughout the program. The timeline can vary based on individual factors such as starting weight, metabolism, and adherence to the treatment plan.